Back to search
PDR - Proliferative Diabetic Retinopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which PDR - Proliferative Diabetic Retinopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which PDR - Proliferative Diabetic Retinopathy trials you may qualify forThe purpose of this trial is to study the safety and effectiveness of OTX-TKI (axitinib intravitreal hydrogel) for the treatment of Non-Proliferative Diabetic R…
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combination a of faricima…
The goal of this clinical trial is to learn about the safety of the investigational medicinal product ANXV. It will also learn about how ANXV works to treat non…
Proliferative diabetic retinopathy (PDR) is the leading cause for blindness in working-age adults. The current gold standard treatment for PDR is panretinal pho…
This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of fol…
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study.…
The purpose of this Phase 2 study is comprised of two groups to evaluate the safety, tolerability, and efficacy of faricimab in patients with Non-Proliferative…
The purpose of this Phase 4 study is to evaluate the safety of aflibercept 8mg in patients with proliferative diabetic retinopathy without center-involved diabe…